Just a few months after dumping its lead asset and cutting its workforce in half, Cargo Therapeutics is jettisoning even more ...
Cargo was founded by two highly acclaimed cell-therapy researchers. The company raised over $500 million to develop ...
Development of CRG-023 and allogeneic platform suspended; further reduction in force (RIF) of approximately 90% to preserve cash and maximize ...
CARGO Therapeutics Stock (CRGX) soared after the company announced a 90% workforce reduction and suspended all pipeline development, with ...
Bay Area's CARGO Therapeutics Cuts Workforce by 90%, Halts Drug Development Amid Financial Struggles
CARGO Therapeutics slashes workforce, halts drug development after a failed trial, with plans for a potential reverse merger.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback